Virtus LifeSci Biotech Products ETF Rating $53.37 -3.28 (-5.79%) As of 04/4/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.77Holdings in BBP have an aggregate rating of Moderate Buy based on 676 analyst ratings issued in the past year covering 50 companies (89.0% of the portfolio).BBP Aggregate Price Target$53.37High Prediction$53.37Average Prediction$53.37Low Prediction$53.37Holdings in BBP have an aggregate price target of $53.37 and a range of $53.37 to $53.37 covering 50 companies (89.0% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.71%ONCBeigene$238.51-9.8%1.9766 of 5 stars3.00$310.00 30.0%3Insider TradeNews CoverageGap Up2.52%ZLABZai Lab$31.77-13.4%1.9692 of 5 stars2.75$47.37 49.1%4Insider TradeNews CoverageGap DownHigh Trading Volume2.50%SAGESage Therapeutics$6.86-6.9%4.0542 of 5 stars2.00$8.81 28.5%19High Trading Volume2.33%HALOHalozyme Therapeutics$59.77-3.5%4.1255 of 5 stars2.60$62.78 5.0%10News CoveragePositive News2.22%TGTXTG Therapeutics$37.35-5.1%2.7928 of 5 stars2.83$40.67 8.9%6Positive NewsGap Down2.19%GILDGilead Sciences$107.25-4.6%4.4578 of 5 stars2.72$105.12 -2.0%29Positive News2.15%BBIOBridgeBio Pharma$31.37-7.9%4.5388 of 5 stars2.92$52.64 67.8%12Insider TradeGap Down2.13%AXSMAxsome Therapeutics$98.86-8.4%4.6295 of 5 stars3.00$167.64 69.6%15Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap Down2.09%ASNDAscendis Pharma A/S$142.67-4.9%2.9361 of 5 stars2.93$204.64 43.4%14News CoveragePositive NewsGap Down2.02%AMGNAmgen$294.39-5.0%4.2929 of 5 stars2.48$314.04 6.7%23Positive News1.95%SWTXSpringWorks Therapeutics$39.09-9.2%1.8216 of 5 stars3.00$73.20 87.3%5Positive NewsGap DownHigh Trading Volume1.95%KNSAKiniksa Pharmaceuticals$20.36-6.4%2.5155 of 5 stars3.00$37.17 82.5%6Positive NewsGap Down1.93%MDGLMadrigal Pharmaceuticals$314.39-3.9%3.3562 of 5 stars2.80$378.44 20.4%10Positive NewsGap Down1.88%VRTXVertex Pharmaceuticals$474.62-1.9%3.6682 of 5 stars2.65$509.17 7.3%26Analyst ForecastNews CoveragePositive NewsHigh Trading Volume1.88%MIRMMirum Pharmaceuticals$42.03-2.8%4.1856 of 5 stars3.09$58.20 38.5%111.88%ALNYAlnylam Pharmaceuticals$235.74-10.1%4.5557 of 5 stars2.77$316.25 34.2%26Analyst ForecastAnalyst RevisionPositive NewsHigh Trading Volume1.88%ADMAADMA Biologics$18.01-7.4%2.0639 of 5 stars3.25$22.50 24.9%4Positive NewsGap Down1.87%EXELExelixis$34.57-5.8%4.4255 of 5 stars2.50$37.59 8.7%20Positive News1.85%BMRNBioMarin Pharmaceutical$60.26-10.7%4.8697 of 5 stars2.71$94.00 56.0%24Analyst DowngradeNews CoveragePositive News1.83%HRMYHarmony Biosciences$29.26-5.5%4.2456 of 5 stars3.00$53.33 82.3%9Gap Down1.81%KRYSKrystal Biotech$171.30-3.8%4.7967 of 5 stars3.00$220.00 28.4%8Analyst RevisionNews CoveragePositive NewsGap Down1.80%INSMInsmed$69.18-5.7%4.2629 of 5 stars3.00$94.00 35.9%16Positive NewsGap Down1.77%PTCTPTC Therapeutics$43.24-7.5%3.7244 of 5 stars2.53$63.77 47.5%15News CoverageGap Down1.76%DVAXDynavax Technologies$12.65-1.6%3.9531 of 5 stars2.33$21.50 70.0%3Positive News1.76%IBRXImmunityBio$2.83-4.7%1.8651 of 5 stars3.00$12.19 330.7%5Gap Down1.76%TVTXTravere Therapeutics$14.99-9.5%2.4484 of 5 stars2.93$31.46 109.9%14Analyst ForecastNews CoverageGap Down1.73%TARSTarsus Pharmaceuticals$47.02-5.1%2.7254 of 5 stars3.00$63.67 35.4%7Positive NewsGap Down1.72%BCRXBioCryst Pharmaceuticals$6.83-6.8%4.1189 of 5 stars2.86$15.57 128.0%7Short Interest ↑Gap Down1.71%ACADACADIA Pharmaceuticals$15.38-4.6%3.9533 of 5 stars2.50$23.93 55.6%16Positive News1.70%IMCRImmunocore$27.26-6.1%1.7472 of 5 stars2.54$65.64 140.8%13Positive NewsGap Down1.67%BPMCBlueprint Medicines$81.68-6.2%2.6322 of 5 stars2.70$124.95 53.0%23News CoveragePositive NewsHigh Trading Volume1.66%LGNDLigand Pharmaceuticals$99.57-3.4%4.3432 of 5 stars3.00$147.00 47.6%6Short Interest ↑Positive NewsGap Down1.65%ARDXArdelyx$4.55-4.0%4.1275 of 5 stars3.00$10.61 133.2%10Gap DownHigh Trading Volume1.65%TBPHTheravance Biopharma$8.44-3.8%1.5316 of 5 stars2.40$13.75 62.9%5Gap Down1.62%RYTMRhythm Pharmaceuticals$46.95-5.8%4.3173 of 5 stars2.92$69.46 47.9%13Gap Down1.60%LEGNLegend Biotech$32.01-2.6%2.4816 of 5 stars2.92$79.00 146.8%12Short Interest ↓News CoveragePositive NewsGap Down1.55%INCYIncyte$60.58-3.0%4.6081 of 5 stars2.21$74.88 23.6%19Positive News1.53%UTHRUnited Therapeutics$292.46-4.8%4.8615 of 5 stars2.67$388.25 32.8%12Positive News1.53%BIIBBiogen$122.98-5.9%4.8372 of 5 stars2.42$213.33 73.5%31Analyst DowngradePositive NewsHigh Trading Volume1.52%NBIXNeurocrine Biosciences$95.65-7.0%4.8144 of 5 stars2.83$163.52 71.0%23Analyst ForecastNews CoverageGap DownHigh Trading Volume1.51%REGNRegeneron Pharmaceuticals$573.45-6.1%4.7342 of 5 stars2.76$966.88 68.6%25Short Interest ↑Analyst RevisionHigh Trading Volume1.50%AUPHAurinia Pharmaceuticals$7.81-3.0%2.3722 of 5 stars3.00$11.50 47.2%2Positive News1.49%ROIVRoivant Sciences$9.46-5.5%2.2636 of 5 stars3.00$17.50 85.0%4Positive News1.41%FOLDAmicus Therapeutics$7.50-6.3%4.0277 of 5 stars2.78$16.75 123.3%9Analyst RevisionNews CoveragePositive News1.35%BNTXBioNTech$88.05-4.3%2.6478 of 5 stars2.89$143.44 62.9%18Analyst ForecastAnalyst RevisionGap Down1.33%IONSIonis Pharmaceuticals$27.09-5.0%4.1765 of 5 stars2.67$58.37 115.5%21Analyst ForecastPositive News1.32%CRSPCRISPR Therapeutics$32.650.0%3.0486 of 5 stars2.48$73.11 123.9%21Gap Down1.30%RAREUltragenyx Pharmaceutical$32.43-7.7%4.3071 of 5 stars2.93$92.79 186.1%14News CoveragePositive NewsGap Down1.29%AGIOAgios Pharmaceuticals$25.76-7.0%4.3592 of 5 stars2.56$56.57 119.6%9Short Interest ↓News CoveragePositive News1.25%APLSApellis Pharmaceuticals$19.97-11.3%4.4887 of 5 stars2.63$45.59 128.3%19Analyst ForecastAnalyst RevisionNews Coverage This page (NYSEARCA:BBP) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBP Stock Free BBP Stock Alerts